Who Paid My Doc
David Turer
Plastic and Reconstructive Surgery Pittsburgh, PA Medical Doctor
NPI 1942563564 CMS profile 4224727
5750 Centre Ave Ste 360, Pittsburgh, PA 15206
General payments
$14,565
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$10,842
Through program year 2025, David Turer of Pittsburgh, PA is reported in the CMS Open Payments database as having received $14,565 across 59 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $10,842 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 87th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $3,546 | 13 | |
| 2024 | General | $3,289 | 8 | |
| 2023 | General | $2,510 | 16 | |
| 2022 | General | $4,477 | 11 | |
| 2021 | General | $745 | 11 |
Beside peers
- David Turer
- Plastic and Reconstructive Surgery median
- Middle half of Plastic and Reconstructive Surgery
- National median
In program year 2025, general payments to David Turer were reported at $3,546. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.
Show as a table
| Year | David Turer | Plastic and Reconstructive Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $335 | $121–$1,264 | $163 |
| 2020 | $0 | $162 | $57–$417 | $114 |
| 2021 | $745 | $245 | $89–$735 | $132 |
| 2022 | $4,477 | $325 | $120–$932 | $149 |
| 2023 | $2,510 | $343 | $129–$999 | $160 |
| 2024 | $3,289 | $390 | $141–$1,085 | $164 |
| 2025 | $3,546 | $442 | $150–$1,242 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
59 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Plastic and Reconstructive Surgery in Pennsylvania
Joseph Serletti
Plastic and Reconstructive Surgery · Philadelphia, PA
Chien-Wei Liao
Plastic and Reconstructive Surgery · Philadelphia, PA
Tobias Long
Plastic and Reconstructive Surgery · Lancaster, PA
Louis Bucky
Plastic and Reconstructive Surgery · Ardmore, PA
Kamran Shayesteh
Plastic and Reconstructive Surgery · Johnstown, PA
John Schantz
Plastic and Reconstructive Surgery · Lancaster, PA
Related records
Plastic and Reconstructive Surgery in Pennsylvania
Practitioners in the same specialty and state, ranked by reported value.
All Plastic and Reconstructive Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Pennsylvania
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.